Insertional oncogenesis in gene therapy: How much of a risk? Journal Article

  

Author:	Sadelain, M.
Article Title:	Insertional oncogenesis in gene therapy: How much of a risk?
Keywords:	leukemia; gene mutation; nonhuman; mouse; animals; mice; cd34 antigen; interleukin 2; interleukin 4; interleukin 7; gene locus; risk assessment; carcinogenesis; gene transfer; transgenic mouse; viral gene delivery system; mus musculus; stem cell; oncogenes; models, animal; gene expression regulation; cytokine; gene disruption; transactivation; gene therapy; retrovirus vector; transgene; virus replication; bone marrow transplantation; combined immunodeficiency; severe combined immunodeficiency; interleukin 15; clinical trials; mutagenesis, insertional; virus vector; plasmid dna; lymphoproliferative disorders; viral gene therapy; unidentified retrovirus; cell oncogene; humans; human; priority journal; article
Journal Title:	Gene Therapy
Volume:	11
Issue:	7
ISSN:	0969-7128
Publisher:	Nature Publishing Group
Date Published:	2004-04-01
Start Page:	569
End Page:	573
Language:	English
DOI:	10.1038/sj.gt.3302243
PROVIDER:	scopus
PUBMED:	15029226
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-1842533449&partnerID=40&md5=c41db78f5bc665132daf33d19ace4b6d
Notes:	Gene Ther. -- Cited By (since 1996):38 -- Export Date: 16 June 2014 -- CODEN: GETHE -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/53331